- Semaglutide is a Breakthrough Drug for Diabetes and Weight Management, known generically as Ozempic (injectable) and Rybelsus (oral), and is a drug used to manage type 2 diabetes and chronic weight issues.
- Approved by the FDA in 2017 and 2021, it is gaining global attention due to its effectiveness in controlling blood sugar, promoting weight loss, and providing cardiovascular benefits.
- It belongs to the Glucagon-like peptide-1 (GLP-1) receptor agonist class, mimicking a hormone that slows digestion, reduces appetite, and triggers insulin release.
- India has over 10 crore diabetes patients, with high obesity prevalence, making semaglutide widely relevant.
- Primarily prescribed for diabetes patients with cardiovascular risks and obesity-resistant to lifestyle changes.
- Not recommended for general weight loss or for individuals without medical indications.
Bottom of FormDig Deeper: Read about the insulin resistance and difference between Type 1 and Type 2 diabetics.
